FBLN5 Gene Cutis Laxa Type 2 Autosomal Dominant Genetic Test
Test Name: FBLN5 Gene Cutis Laxa Type 2 Autosomal Dominant Genetic Test
Components: Blood or Extracted DNA or One drop Blood on FTA Card
Price: 4400.0 AED
Report Delivery: 3 to 4 Weeks
Method: NGS Technology
Test Type: Osteology Dermatology Immunology Disorders
Doctor: Dermatologist
Test Department: Genetics
Pre Test Information: Clinical History of Patient who is going for FBLN5 Gene Cutis Laxa Type 2, Autosomal Dominant NGS Genetic DNA Test. A Genetic Counselling session to draw a pedigree chart of family members affected with FBLN5 Gene Cutis Laxa Type 2, Autosomal Dominant NGS Genetic DNA Test gene FBLN5.
Test Details
The FBLN5 gene is associated with a condition called cutis laxa type 2, which is an autosomal dominant disorder. Cutis laxa is a connective tissue disorder characterized by loose, sagging skin and other connective tissue abnormalities.
NGS (Next-Generation Sequencing) genetic testing is a technique used to analyze multiple genes simultaneously. In the context of cutis laxa type 2, NGS genetic testing can be used to identify mutations or variations in the FBLN5 gene that may be responsible for the condition.
This type of genetic testing involves sequencing the DNA of an individual to detect any changes or mutations in the FBLN5 gene. It can provide valuable information about the genetic cause of cutis laxa type 2, which can aid in diagnosis, genetic counseling, and potentially guide treatment options.
It is important to note that genetic testing should be performed by a qualified healthcare professional or genetic counselor who can interpret the results and provide appropriate guidance and support.
| Test Name | FBLN5 Gene Cutis laxa type 2 autosomal dominant Genetic Test |
|---|---|
| Components | |
| Price | 4400.0 AED |
| Sample Condition | Blood or Extracted DNA or One drop Blood on FTA Card |
| Report Delivery | 3 to 4 Weeks |
| Method | NGS Technology |
| Test type | Osteology Dermatology Immunology Disorders |
| Doctor | Dermatologist |
| Test Department: | Genetics |
| Pre Test Information | Clinical History of Patient who is going for FBLN5 Gene Cutis laxa type 2, autosomal dominant NGS Genetic DNA Test. A Genetic Counselling session to draw a pedigree chart of family members affected with FBLN5 Gene Cutis laxa type 2, autosomal dominant NGS Genetic DNA Test gene FBLN5 |
| Test Details |
The FBLN5 gene is associated with a condition called cutis laxa type 2, which is an autosomal dominant disorder. Cutis laxa is a connective tissue disorder characterized by loose, sagging skin and other connective tissue abnormalities. NGS (Next-Generation Sequencing) genetic testing is a technique used to analyze multiple genes simultaneously. In the context of cutis laxa type 2, NGS genetic testing can be used to identify mutations or variations in the FBLN5 gene that may be responsible for the condition. This type of genetic testing involves sequencing the DNA of an individual to detect any changes or mutations in the FBLN5 gene. It can provide valuable information about the genetic cause of cutis laxa type 2, which can aid in diagnosis, genetic counseling, and potentially guide treatment options. It is important to note that genetic testing should be performed by a qualified healthcare professional or genetic counselor who can interpret the results and provide appropriate guidance and support. |
